Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial
The objective of our research is to assess the effect of radiotherapy coupled with TMZ in high-risk patients with LGGs after surgery, compared with RT alone. Different histological types and molecular subtypes will be examined, and a corresponding subgroup analysis will be conducted. Our data can provide evidence for postoperative adjuvant therapy in patients with high-risk LGGs in China.Trial registrationChinese Clinical Trial Registry,ChiCTR1800015199. Registered on 13 March 2018.
Source: Trials - Category: Research Source Type: clinical trials
More News: Brain Tumor | Chemotherapy | China Health | Clinical Trials | Glioma | International Medicine & Public Health | Radiation Therapy | Research | Study | Temodar | WHO